SEC Company Response from MEDSTRONG INTERNATIONAL CORP (CIK 0001136711) — Aug 4, 2005
MEDSTRONG INTERNATIONAL CORP (CIK 0001136711)
Date: Aug. 4, 2005 · CIK: 0001136711 · Accession: 0001144204-05-023800
AI Filing Summary & Sentiment
Referenced dates: July 27, 2005
Letter
[MEDSTRONG INTERNATIONAL CORPORATION LETTERHEAD] August 4, 2005 Securities and Exchange Commission Washington, D.C. 20549
Dear Sir/Madam:
Medstrong International Corporation received the Commission's staff's comment letter dated July 27, 2005, signed by Thomas Flinn, Staff Accountant, on Medstrong's Form 8-K, filed July 26, 2005. Medstrong filed an amended Form 8-K on July 29, 2005, responding to the comments in the Commission's July 27, 2005 letter.
This is to confirm that Medstrong takes responsibility for the accuracy and adequacy of the disclosure in the filing; staff comments do not foreclose the Commission from taking any action with respect to the filing; and that Medstrong may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
I am also aware that the Division of Enforcement has access to all information we provide to the staff of the Division of Corporation Finance in your review of our filing or in response to your comments on our filing.
Sincerely,
/s/Jeanine M. Folz
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
[MEDSTRONG INTERNATIONAL CORPORATION LETTERHEAD]
August 4, 2005
Securities and Exchange Commission
Washington, D.C. 20549
Dear Sir/Madam:
Medstrong International Corporation received the Commission's staff's
comment letter dated July 27, 2005, signed by Thomas Flinn, Staff Accountant, on
Medstrong's Form 8-K, filed July 26, 2005. Medstrong filed an amended Form 8-K
on July 29, 2005, responding to the comments in the Commission's July 27, 2005
letter.
This is to confirm that Medstrong takes responsibility for the accuracy
and adequacy of the disclosure in the filing; staff comments do not foreclose
the Commission from taking any action with respect to the filing; and that
Medstrong may not assert staff comments as a defense in any proceeding initiated
by the Commission or any person under the federal securities laws of the United
States.
I am also aware that the Division of Enforcement has access to all
information we provide to the staff of the Division of Corporation Finance in
your review of our filing or in response to your comments on our filing.
Sincerely,
/s/Jeanine M. Folz
Jeanine M. Folz
Chief Executive Officer
Medstrong International Corporation
</TEXT>
</DOCUMENT>